Clinical Trial Update: Long-Term Safety and Efficacy of Repeat Treatments of DaxibotulinumtoxinA for Injection in Adults With Isolated Cervical Dystonia (ASPEN-OLS) [Phase 3]

View source ↗

Summary

Phase 3 long-term safety and efficacy update for repeat treatments of DaxibotulinumtoxinA for injection in adults with isolated cervical dystonia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Dystonia

Drugs mentioned

• DaxibotulinumtoxinA for Injection (daxibotulinumtoxinA)

Snippet

Sponsor: Revance Therapeutics, Inc. | Conditions: Cervical Dystonia | Phase 3 | Status: COMPLETED